Clinical Trials Directory

Trials / Conditions / Renal Anemia

Renal Anemia

29 registered clinical trials studyying Renal Anemia — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEffects of Vadadustat on Anemia, Quality of Life, and Inflammation in Dialysis Patients
NCT07537816
Mackay Memorial HospitalPhase 4
Not Yet RecruitingIron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients
NCT06830941
Xie Jingyuan, MDPhase 4
RecruitingA Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
NCT05970172
Astellas Pharma Global Development, Inc.Phase 3
CompletedA Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From
NCT05951192
USRC Kidney ResearchPhase 4
CompletedPharmacokinetics Comparison Study of JT1801 and NESP® After Single Dose Administration in Chinese Health Male
NCT05864261
Yi FangPhase 4
CompletedA Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis
NCT05265325
Kind Pharmaceuticals LLCPhase 2
UnknownA Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia .
NCT05629598
Angde Biotech Pharmaceutical Co., Ltd.Phase 2
CompletedFerric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
NCT05085275
USRC Kidney ResearchPhase 3
CompletedHEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia
NCT04925661
Sunshine Lake Pharma Co., Ltd.Phase 1
CompletedA Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients
NCT05035641
Kind Pharmaceuticals LLCPhase 2
Active Not RecruitingA Study to Learn More About the Long-term Safety and Effectiveness of Molidustat as a Treatment for Japanese M
NCT04899661
Bayer—
UnknownMulti-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics
NCT04775615
Jiangsu HengRui Medicine Co., Ltd.Phase 1
CompletedDifferent Doses of Roxadustat Treatment for Anemia in Peritoneal Dialysis Patients
NCT04454879
Peking University First HospitalPhase 4
CompletedPost-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia
NCT04408820
Astellas Pharma Inc—
CompletedThe Association Between the Distributions MCH and RBC, and Mortality in Hemodialysis Patients
NCT04227158
University of Hyogo—
UnknownAssessment of an Anemia Model Predictive Controller for Anemia Management in Hemodialysis Patients
NCT04360902
Renal Research InstituteN/A
UnknownRenal Anemia Refractory to Erythropoietin
NCT03480178
Assiut University—
UnknownAcute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD
NCT03388385
Carol Davila University of Medicine and PharmacyPhase 4
CompletedStudy to Compare the Safety and Efficacy of UB-851 and Eprex®
NCT02708914
UBI Pharma Inc.Phase 3
CompletedBiosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)
NCT02947438
Shenyang Sunshine Pharmaceutical Co., LTD.Phase 3
CompletedPilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease
NCT02299661
Daiichi SankyoPhase 1
CompletedRenal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Ag
NCT02136563
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan—
CompletedVariability of Hemoglobin Levels After Kidney Transplantation
NCT02041208
Sociedad Española de Trasplante—
CompletedNeocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)
NCT01306409
University Hospital, Basel, SwitzerlandPhase 4
CompletedPost-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the
NCT01543477
Pfizer—
CompletedStudy to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With A
NCT00717366
Hoffmann-La RochePhase 2
CompletedA Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis
NCT00456053
Kyntra BioPhase 2
CompletedEfficacy of Intravenous Iron Administration in Hemodialysis Patients
NCT00298441
Kumamoto UniversityPhase 4
CompletedComparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial
NCT00322413
General Hospital Sveti DuhPhase 3